|
Volumn 526, Issue 2, 2012, Pages 146-153
|
Mechanism of action of therapeutic monoclonal antibodies: Promises and pitfalls of in vitro and in vivo assays
|
Author keywords
ADCC; Antibody; Cell death; Complement; Phagocytosis
|
Indexed keywords
3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE;
ALEMTUZUMAB;
BRENTUXIMAB VEDOTIN;
CALCEIN;
CALICHEAMICIN;
CD16 ANTIGEN;
CD20 ANTIBODY;
CETUXIMAB;
CHROMIUM 51;
COMPLEMENT COMPONENT C3B;
COMPLEMENT COMPONENT C3D;
COMPLEMENT COMPONENT C4;
COMPLEMENT COMPONENT C5A;
COMPLEMENT COMPONENT C9;
DACLIZUMAB;
DUOCARMYCIN DERIVATIVE;
GEMTUZUMAB OZOGAMICIN;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOGLOBULIN FC FRAGMENT;
MAYTANSINE;
MONOCLONAL ANTIBODY;
PROPIDIUM IODIDE;
RITUXIMAB;
TRASTUZUMAB;
TRASTUZUMAB EMTANSINE;
TRYPAN BLUE;
VEDOTIN;
ANTIBODY SCREENING;
APOPTOSIS;
BIOASSAY;
CANCER CELL CULTURE;
CELL ASSAY;
CELL PROLIFERATION;
COLORECTAL CARCINOMA;
COMPLEMENT ACTIVATION;
COMPLEMENT DEPENDENT CYTOTOXICITY;
DISEASE MODEL;
DNA FRAGMENTATION;
DRUG ACTIVITY;
DRUG CYTOTOXICITY;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG SCREENING;
EFFECTOR CELL;
FLOW CYTOMETRY;
FLUORESCENCE ACTIVATED CELL SORTING;
FLUORESCENCE MICROSCOPE;
GRAFT REJECTION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INNATE IMMUNITY;
LUNG SMALL CELL CANCER;
MONOCYTE;
NATURAL KILLER CELL MEDIATED CYTOTOXICITY;
NICK END LABELING;
NONHUMAN;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
REVIEW;
SCID MOUSE;
WESTERN BLOTTING;
ANIMALS;
ANTIBODIES, BISPECIFIC;
ANTIBODIES, MONOCLONAL;
CELL DEATH;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
IMMUNE SYSTEM;
IMMUNOCONJUGATES;
IMMUNOGLOBULIN FRAGMENTS;
PHAGOCYTOSIS;
ANIMALIA;
|
EID: 84865699475
PISSN: 00039861
EISSN: 10960384
Source Type: Journal
DOI: 10.1016/j.abb.2012.02.011 Document Type: Review |
Times cited : (95)
|
References (114)
|